Pharm Company: * TEVA PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Axitinib Overview

Axitinib, sold under the brand name Inlyta, is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models[3] and has shown partial responses in clinical trials with renal cell carcinoma (RCC)[4] and several other tumour types.[5] It was approved to treat renal cell carcinoma by the U.S. Food and Drug Administration after showing a modest increase...

Read more Axitinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Axitinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 1mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Axitinib or a similar ingredient: (1 result)

Related Axitinib Topics:

angiogenesis inhibitor...